PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.
暂无分享,去创建一个
X. Matías-Guiu | A. Velasco | X. Dolcet | J. Prat | J. Palacios | E. Bussaglia | M. Encinas | J. Pallarés | D. Llobet | N. Llecha
[1] Frank McCormick,et al. High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma. , 2005, Cancer research.
[2] J. Ptak,et al. Colorectal cancer: Mutations in a signalling pathway , 2005, Nature.
[3] S. Schwartz,et al. The prevalence of PIK3CA mutations in gastric and colon cancer. , 2005, European journal of cancer.
[4] T. Kawabe,et al. Functional analysis of PIK3CA gene mutations in human colorectal cancer. , 2005, Cancer research.
[5] Xin Huang,et al. Somatic mutation and gain of copy number of PIK3CA in human breast cancer , 2005, Breast Cancer Research.
[6] A. Børresen-Dale,et al. PIK3CA mutations in advanced ovarian carcinomas , 2005, Human mutation.
[7] P. Vogt,et al. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[8] Wei Zhao,et al. Mutations of PIK3CA in gastric adenocarcinoma , 2005, BMC Cancer.
[9] Wayne A. Phillips,et al. Mutation of the PIK3CA Gene in Ovarian and Breast Cancer , 2004, Cancer Research.
[10] A. Ashworth,et al. Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way. , 2004, Biochimica et biophysica acta.
[11] William R Sellers,et al. PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling. , 2003, Cancer treatment and research.
[12] M. Shigemori,et al. Autocrine Signaling through Ras Regulates Cell Survival Activity in Human Glioma Cells: Potential Cross‐Talk between Ras and the Phosphatidylinositol 3‐Kinase‐Akt Pathway , 2002, Journal of neuropathology and experimental neurology.
[13] C. Downes,et al. PTEN: The down side of PI 3-kinase signalling. , 2002, Cellular signalling.
[14] B. Bapat,et al. Considerations when analyzing the methylation status of PTEN tumor suppressor gene. , 2002, The American journal of pathology.
[15] X. Matías-Guiu,et al. CTNNB1 mutations and β-catenin expression in endometrial carcinomas , 2002 .
[16] I. Pass,et al. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN. , 2001, Biochemical Society transactions.
[17] M. Ittmann,et al. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Kigawa,et al. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[19] X. Matías-Guiu,et al. K‐ras mutations in endometrial carcinomas with microsatellite instability , 2001, The Journal of pathology.
[20] Soma Das,et al. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma , 2001, International journal of cancer.
[21] J. Downward,et al. Ras activation of phosphatidylinositol 3-kinase and Akt. , 2001, Methods in enzymology.
[22] C. Eng,et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. , 2000, Journal of the National Cancer Institute.
[23] F. Haluska,et al. Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines. , 2000, Cancer research.
[24] X. Matías-Guiu,et al. PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases. , 2000, Human pathology.
[25] W. Sellers,et al. The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. , 2000, Biochimica et biophysica acta.
[26] L. Schriml,et al. Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. , 1999, Journal of the National Cancer Institute.
[27] J. Dixon,et al. PTEN: a tumour suppressor that functions as a phospholipid phosphatase. , 1999, Trends in cell biology.
[28] X. Matías-Guiu,et al. Microsatellite instability in endometrial carcinomas: clinicopathologic correlations in a series of 42 cases. , 1998, Human pathology.
[29] R. Levine,et al. PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. , 1998, Cancer research.
[30] A. Berchuck,et al. PTEN/MMAC1 mutations in endometrial cancers. , 1997, Cancer research.
[31] A. Sakurada,et al. PTEN1 is frequently mutated in primary endometrial carcinomas , 1997, Nature Genetics.
[32] Kathleen R. Cho,et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. , 1997, Cancer research.
[33] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[34] S. Sato,et al. Deletion mapping on chromosome 10q25-q26 in human endometrial cancer. , 1996, British Journal of Cancer.
[35] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[36] J. Weissenbach,et al. Loss of the chromosomal region 10q23-25 in prostate cancer. , 1995, Cancer research.
[37] R. McLendon,et al. Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. , 1995, Oncogene.
[38] P. Goodfellow,et al. Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. , 1995, Cancer research.
[39] L. Cantley,et al. Purification and characterization of phosphoinositide 3-kinase from rat liver. , 1990, The Journal of biological chemistry.